参考文献

1.Yu, L.X. (1999). An integrated model for determining causes of poor oral drug absorption. Pharm. Res ., 16, 1883–1887.

2.Sugano, K., Okazaki, A., Sugimoto, S., Tavornvipas, S., Omura, A., Mano, T. (2007).Solubility and dissolution profile assessment in drug discovery. Drug Metab. Pharmacokinet .,22, 225–254.

3.Sugano, K., Kataoka, M., Mathews, C.d.C., Yamashita, S. (2010). Prediction of food effect by bile micelles on oral drug absorption considering free fraction in intestinal fluid. Eur. J.Pharm. Sci ., 40, 118–124.

4.Sugano, K. (2011). Fraction of a dose absorbed estimation for structurally diverse low solubility compounds. Int. J. Pharm ., 405, 79–89.

5.Johnson, K.C. (2003). Dissolution and absorption modeling: model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption. Drug Dev. Ind. Pharm ., 29, 833–842.

6.Sugano, K. Computational oral absorption simulation of free base drugs. (2010). Int. J.Pharm ., 398(1–2), 73–82.

7.Sugano, K. (2009). Introduction to computational oral absorption simulation. Expert Opin.Drug Metab. Toxicol ., 5, 259–293.

8.Wessel, M.D., Jurs, P.C., Tolan, J.W., Muskal, S.M. (1998). Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci ., 38, 726–735.

9.Turner, J.V., Maddalena, D.J., Agatonovic-Kustrin, S. (2004). Bioavailability prediction based on molecular structure for a diverse series of drugs. Pharm. Res ., 21, 68–82.

10.Klopman, G., Stefan, L.R., Saiakhov, R.D. (2002). ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci ., 17, 253–263.

11.Tian, S., Li, Y., Wang, J., Zhang, J., Hou, T. (2011). ADME evaluation in drug discovery.

12.Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints. Mol. Pharm ., 8, 841–851. EQ+meGEoyRPm3sN+OhVtTlYiORqJ8TRgccN3RvYc9FR8nudi4hI7F/i5gG9uTQUm